1-153261059-T-TCGG
Position:
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 1P and 9B. PM4_SupportingBP6BS1BS2
The NM_000427.3(LORICRIN):c.121_123dupGGC(p.Gly41dup) variant causes a conservative inframe insertion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00431 in 1,513,536 control chromosomes in the GnomAD database, including 18 homozygotes. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: 𝑓 0.0035 ( 0 hom., cov: 31)
Exomes 𝑓: 0.0044 ( 18 hom. )
Consequence
LORICRIN
NM_000427.3 conservative_inframe_insertion
NM_000427.3 conservative_inframe_insertion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: -0.0520
Genes affected
LORICRIN (HGNC:6663): (loricrin cornified envelope precursor protein) This gene encodes loricrin, a major protein component of the cornified cell envelope found in terminally differentiated epidermal cells. Mutations in this gene are associated with Vohwinkel's syndrome and progressive symmetric erythrokeratoderma, both inherited skin diseases. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -8 ACMG points.
PM4
Nonframeshift variant in NON repetitive region in NM_000427.3. Strenght limited to Supporting due to length of the change: 1aa.
BP6
Variant 1-153261059-T-TCGG is Benign according to our data. Variant chr1-153261059-T-TCGG is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 587580.We mark this variant Likely_benign, oryginal submissions are: {Uncertain_significance=1, Benign=2}.
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.00351 (500/142352) while in subpopulation NFE AF= 0.00572 (368/64352). AF 95% confidence interval is 0.00524. There are 0 homozygotes in gnomad4. There are 236 alleles in male gnomad4 subpopulation. Median coverage is 31. This position pass quality control queck.
BS2
High AC in GnomAd4 at 500 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LORICRIN | NM_000427.3 | c.121_123dupGGC | p.Gly41dup | conservative_inframe_insertion | 2/2 | ENST00000368742.4 | NP_000418.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LORICRIN | ENST00000368742.4 | c.121_123dupGGC | p.Gly41dup | conservative_inframe_insertion | 2/2 | 1 | NM_000427.3 | ENSP00000357731.3 |
Frequencies
GnomAD3 genomes AF: 0.00352 AC: 500AN: 142234Hom.: 0 Cov.: 31
GnomAD3 genomes
AF:
AC:
500
AN:
142234
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00277 AC: 452AN: 163130Hom.: 1 AF XY: 0.00295 AC XY: 271AN XY: 91822
GnomAD3 exomes
AF:
AC:
452
AN:
163130
Hom.:
AF XY:
AC XY:
271
AN XY:
91822
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00439 AC: 6023AN: 1371184Hom.: 18 Cov.: 44 AF XY: 0.00433 AC XY: 2947AN XY: 679828
GnomAD4 exome
AF:
AC:
6023
AN:
1371184
Hom.:
Cov.:
44
AF XY:
AC XY:
2947
AN XY:
679828
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00351 AC: 500AN: 142352Hom.: 0 Cov.: 31 AF XY: 0.00339 AC XY: 236AN XY: 69664
GnomAD4 genome
AF:
AC:
500
AN:
142352
Hom.:
Cov.:
31
AF XY:
AC XY:
236
AN XY:
69664
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:2
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Jan 01, 2023 | LORICRIN: BS1, BS2 - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Nov 27, 2023 | - - |
Loricrin keratoderma Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Genomic Research Center, Shahid Beheshti University of Medical Sciences | Aug 07, 2018 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at